Viral vector-based therapeutic cancer vaccines
C Larocca, J Schlom - The Cancer Journal, 2011 - journals.lww.com
Most viruses are naturally immunogenic and can be engineered to express tumor antigen
transgenes. Moreover, many types of recombinant viruses have been shown to infect …
transgenes. Moreover, many types of recombinant viruses have been shown to infect …
[HTML][HTML] Insight to drug delivery aspects for colorectal cancer
Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide in human
beings. Surgery, chemotherapy, radiotherapy and targeted therapies are the conventional …
beings. Surgery, chemotherapy, radiotherapy and targeted therapies are the conventional …
Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy
M Chakraborty, SI Abrams, K Camphausen… - The Journal of …, 2003 - journals.aai.org
CD8+ CTL play important roles against malignancy in both active and passive
immunotherapy. Nonetheless, the success of antitumor CTL responses may be improved by …
immunotherapy. Nonetheless, the success of antitumor CTL responses may be improved by …
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients
K Odunsi, J Matsuzaki, J Karbach… - Proceedings of the …, 2012 - National Acad Sciences
Recombinant poxviruses (vaccinia and fowlpox) expressing tumor-associated antigens are
currently being evaluated in clinical trials as cancer vaccines to induce tumor-specific …
currently being evaluated in clinical trials as cancer vaccines to induce tumor-specific …
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
RA Madan, PM Arlen, M Mohebtash… - Expert opinion on …, 2009 - Taylor & Francis
Prostvac is a prostate cancer vaccine regimen consisting of a recombinant vaccinia vector
as a primary vaccination, followed by multiple booster vaccinations employing a …
as a primary vaccination, followed by multiple booster vaccinations employing a …
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.
PM Arlen, JL Gulley, C Parker, L Skarupa… - Clinical cancer research …, 2006 - AACR
PURPOSE: Docetaxel has activity against androgen-independent prostate cancer and
preclinical studies have shown that taxane-based chemotherapy can enhance antitumor …
preclinical studies have shown that taxane-based chemotherapy can enhance antitumor …
A triad of costimulatory molecules synergize to amplify T-cell activation
JW Hodge, H Sabzevari, A Gómez Yafal, L Gritz… - Cancer research, 1999 - AACR
The activation of a T cell has been shown to require two signals via molecules present on
professional antigen-presenting cells: signal 1, via a peptide/MHC complex; and signal 2 …
professional antigen-presenting cells: signal 1, via a peptide/MHC complex; and signal 2 …
Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement
CT Garnett, J Schlom, JW Hodge - Clinical Cancer Research, 2008 - AACR
Purpose: Taxanes comprise some of the most widely used cancer chemotherapeutic agents.
Members of this drug family, including docetaxel, are commonly used to treat breast …
Members of this drug family, including docetaxel, are commonly used to treat breast …
HER-2/neu Is a Tumor Rejection Target in Tolerized HER-2/neu Transgenic Mice
RT Reilly, MBC Gottlieb, AM Ercolini, JPH Machiels… - Cancer research, 2000 - AACR
Abstract HER-2/neu (neu-N) transgenic mice, which express the nontransforming rat proto-
oncogene, develop spontaneous focal mammary adenocarcinomas beginning at 5–6 …
oncogene, develop spontaneous focal mammary adenocarcinomas beginning at 5–6 …
Strategies for cancer vaccine development
M Vergati, C Intrivici, NY Huen… - BioMed research …, 2010 - Wiley Online Library
Treating cancer with vaccines has been a challenging field of investigation since the 1950s.
Over the years, the lack of effective active immunotherapies has led to the development of …
Over the years, the lack of effective active immunotherapies has led to the development of …